{
  "ticker": "JNJ",
  "target_date": "2025-09-23",
  "actual_date": "2025-09-23",
  "collected_at": "2025-12-08T12:18:51.877510",
  "price": {
    "open": 173.79,
    "high": 175.85,
    "low": 173.73,
    "close": 175.46592712402344,
    "volume": 8350400,
    "change_1d_pct": 1.36,
    "change_7d_pct": -0.83,
    "change_30d_pct": 2.33
  },
  "technicals": {
    "rsi_14": 46.19,
    "sma_20": 175.82,
    "sma_50": 171.32,
    "macd": 0.906,
    "macd_signal": 1.599,
    "macd_histogram": -0.693,
    "bb_upper": 178.45,
    "bb_lower": 173.2,
    "price_vs_sma20_pct": -0.2,
    "price_vs_sma50_pct": 2.42,
    "volume_ratio": 1.01
  },
  "fundamentals": {
    "market_cap": 487424491520,
    "pe_ratio": 19.527992,
    "forward_pe": 19.085848,
    "price_to_book": 6.140468,
    "price_to_sales": 5.2895255,
    "profit_margin": 27.26,
    "operating_margin": 30.2,
    "roe": 33.62,
    "roa": 8.26,
    "revenue_growth": 6.8,
    "earnings_growth": 91.0,
    "debt_to_equity": 57.766,
    "current_ratio": 1.074,
    "quick_ratio": 0.711,
    "dividend_yield": 258.0,
    "fifty_two_week_high": 207.81,
    "fifty_two_week_low": 140.68,
    "fifty_day_avg": 193.4922,
    "two_hundred_day_avg": 170.2741,
    "analyst_target": 203.41833,
    "analyst_recommendation": "buy",
    "num_analysts": 24,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - General",
    "pct_from_52w_high": -2.65,
    "pct_from_52w_low": 43.81
  },
  "macro": {
    "spy": {
      "price": 663.21,
      "change_1d_pct": -0.54,
      "change_7d_pct": 0.63
    },
    "vix": {
      "level": 16.64,
      "signal": "NORMAL"
    },
    "treasury_10y": {
      "yield_pct": 4.12
    },
    "dollar_index": {
      "level": 97.26
    },
    "gold": {
      "price": 3780.6
    },
    "regime": "BULL_NORMAL"
  },
  "news": [
    {
      "headline": "Johnson & Johnson (JNJ) Gains FDA Nod for Subcutaneous Tremfya in Ulcerative Colitis",
      "source": "Yahoo",
      "datetime": 1758668521,
      "summary": "In this article, we will be taking a look at the 10 Best Pharma Stocks to Buy According to Billionaires. Johnson & Johnson is one of them. Johnson & Johnson (NYSE:JNJ), a global healthcare leader, continues to strengthen its pharmaceuticals and immunology portfolio while delivering strong stock perf",
      "url": "https://finnhub.io/api/news?id=a5f76184c324ff4443a6c17f9f2d51ceaea4296e4a285cb2da331eebbafadaac"
    },
    {
      "headline": "Tracking John Paulson's Paulson & Company Portfolio - Q2 2025 Update",
      "source": "SeekingAlpha",
      "datetime": 1758661384,
      "summary": "John Paulson's Paulson & Company 13F portfolio rose to ~$2.01B in Q2 2025. Check out the significant stake increases and new stakes in the portfolio.",
      "url": "https://finnhub.io/api/news?id=ecb7703b60633f97c48bb557e6d9dff98e5680c8395fe5c43ae2d71bc7082789"
    },
    {
      "headline": "Kenvue stock rebounds as Trump's Tylenol claims face pushback",
      "source": "Yahoo",
      "datetime": 1758650388,
      "summary": "STORY: Shares of Tylenol-maker Kenvue rose as much as 7% Tuesday morning, rebounding from a record low after investors shrugged off unproven claims from U.S. President Donald Trump linking the popular pain reliever to autism.On Monday, Trump connected autism to the use of Tylenol\u2014known generically a",
      "url": "https://finnhub.io/api/news?id=7f349f8d2ebb3ea89cdca25f1450414b08b2e77b3094a8208653e3684e3cbef7"
    },
    {
      "headline": "Sector Update: Health Care Stocks Advance Tuesday Afternoon",
      "source": "Yahoo",
      "datetime": 1758649504,
      "summary": "Health care stocks rose Tuesday afternoon, with the NYSE Health Care Index up 0.2% and the Health Ca",
      "url": "https://finnhub.io/api/news?id=dd1362e8bb7cc4ade20e4781ecc3e08dcf671542f506e7ed6e02e9de0a5de871"
    },
    {
      "headline": "Guggenheim Upgrades Johnson & Johnson (JNJ)",
      "source": "Fintel",
      "datetime": 1758645027,
      "summary": "",
      "url": "https://finnhub.io/api/news?id=bddadc80199f05afc8d49e46bb56feee536f94f97f74ca91def274cee4bc3c8b"
    }
  ],
  "news_count": 5,
  "sec_filings": [
    {
      "form": "4",
      "date": "2025-09-11",
      "description": "xslF345X05/wk-form4_1757627547.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000196/xslF345X05/wk-form4_1757627547.xml"
    },
    {
      "form": "4",
      "date": "2025-09-11",
      "description": "xslF345X05/wk-form4_1757627315.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000194/xslF345X05/wk-form4_1757627315.xml"
    },
    {
      "form": "4",
      "date": "2025-09-11",
      "description": "xslF345X05/wk-form4_1757627206.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000192/xslF345X05/wk-form4_1757627206.xml"
    },
    {
      "form": "8-K",
      "date": "2025-09-09",
      "description": "jnj-20250908.htm",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000190/jnj-20250908.htm"
    },
    {
      "form": "4",
      "date": "2025-09-05",
      "description": "xslF345X05/wk-form4_1757109644.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000186/xslF345X05/wk-form4_1757109644.xml"
    }
  ],
  "sec_filings_count": 5,
  "data_quality": {
    "has_price": true,
    "has_technicals": true,
    "has_fundamentals": true,
    "has_macro": true,
    "has_news": true,
    "has_sec_filings": true
  }
}